Page 12 of 33 · 771 questions tagged coa.
The specifics, since they change the answer: identity confirmation by mass spectrometry · a twenty-person split. I would like to define my thresholds before I have a…
Numbers first: 98.4% · Janoshik · 98.2%. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the…
What I am working with: Janoshik · a GLP-1 receptor agonist. This is a procedural question rather than a theoretical one, and I would like the procedure rather than…
Setup, so nobody has to ask: orforglipron · Medutest. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Costs, fees and monitoring all included, I am trying to compare like with like. I can predict the outcome but I cannot explain it, which means I will get the next…
What I am working with: mazdutide · six weeks · room temperature. This is a planning question. I know what my options are; I do not know how to weigh them. What I…
Details up front: TFC · liraglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Can…
Concretely: 98.2% · date of analysis. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
Details up front: sampling plan · FGP. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
I would like to understand the process rather than be told to try harder. I want to know whether this is a real physical effect or an artefact of how it is measured.…
I have a COA in front of me with all of the following on it, and I cannot work out which of these numbers is the one I care about: Appearance: white lyophilised…
For reference: lot-specific certificate · SWB. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided…
The case in front of me: 99.1% · VendorInvestigate · 96.8%. I have two candidate explanations and no way to distinguish them. The same procedure has worked without…
Conditions: list of related substances · MKM. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Setup, so nobody has to ask: survodutide · date of analysis. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
What I have: CPC · a sterility test. Please show the division. I want to check my own against yours. I would like the general form as well as the specific number, so…
What I have: MKM · Qingdao Saber Technology. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and…
Details up front: Homopeptide · Shanghai Wibson Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option…
What I am working with: PeptideMeter · oral semaglutide. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made…
The specifics, since they change the answer: a quantified content assay · liraglutide. I would like the axes of comparison first and the recommendation second. I have…
The lane and the lead time matter as much as the material for what I am doing. I have the document in front of me and I can read the numbers. What I cannot do is…
The method section is present, which is unusual enough that I want to make use of it. I am trying to build something sustainable rather than something thorough that I…
What I am working with: 98.2% · Medutest · 96.4%. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
What I have: 96.4% · Janoshik · 98.8%. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the…